MEI Pharma Corporation - MEIP Net Assets per Single Share

Public company logo of MEI Pharma Inc (MEIP)

MEI Pharma, Inc. (MEIP) maintains a strong reputation for developing precision medicines to combat oncohematology. This book value per share chart visualizes capital dynamics, where the 2.91 metric determines this level. The company is building a network of targeted solutions for the therapy of resistant tumors, capturing a promising niche characterized by a shortage of effective treatment methods and immense market potential.

MEI Pharma Inc (MEIP) - Accounting Value per Share from 07/04/2022 to 09/11/2025

Summary analytical data breakdowns for meipharma.com (MEIP)

- price and consensus price forecast:
Stock Price MEI Pharma Corp|MEIP - Analyst Median Target
- market capitalization data:
Market Value MEI Pharma, Inc.|MEIP - Full Business Value
- book capitalization data:
Book Value per Share MEI Pharma|MEIP - Company Net Assets|Market Capitalization to Book Value Ratio meipharma.com|MEIP - Company Total Assets
- debt and liquidity data:
Debt to Equity MEI Pharma, Inc.|MEIP - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital MEI Pharma|MEIP - Company Total Debt|Debts to Book Capitalization MEI Pharma, Inc.
Analysis of all company metrics:MEI Pharma Corp, MEIP
Manufactured product of meipharma.com

Diversifying the hematological molecule portfolio across various trial stages minimizes risks for MEI Pharma, Inc. (MEIP), creating a resilient base of tangible assets. An analysis of the adjusted book value per share determines the net asset value per share, which, amid interest rate volatility, helps assess real capital protection against inflation and the fundamental security of investments against business model obsolescence.

Competitor analysis for MEI Pharma, Inc.

Book Value per Share TGTX (TG Therapeutics Corp)|ACLX: Net Assets per Share|Net Assets per Single Share Disc Medicine, Inc. (IRON)|syndax.com (SNDX) - Share Book Value|Book Value per Share KURA|Accounting Value per Share ADC Therapeutics S.A.|Book Value per Share FHTX|Book Value per Share VOR (Vor Bio Inc.)|NKTX - Net Assets per Single Share|Equity per Share Coeptis Therapeutics Inc. COEP|ATNM: Book Value per Share|ESLA - Accounting Value per Share|Book Value per Share CASI|MRKR (Marker Therapeutics, Inc.) - Net Asset Value per Share|INAB - Net Assets per Single Share|Accounting Value of a Share Eterna Therapeutics Inc (ERNA)|GT Biopharma (GTBP) - Accounting Value per Share|Accounting Value of a Share aptose.com (APTO)|Book Value per Share Bio-Path BPTH|Vincerx Pharma Inc. - Net Assets per Single Share